title: Reduced sympathetic innervation after alteration of target cell neurotransmitter phenotype in transgenic mice.
abstract: Neurotransmitters play a variety of important roles during nervous system development. In the present study, we hypothesized that neurotransmitter phenotype of both projecting and target cells is an important factor for the final synaptic linkage and its specificity. To test this hypothesis, we used transgenic techniques to convert serotonin/melatonin-producing cells of the pineal gland into cells that also produce dopamine and investigated the innervation of the phenotypically altered target cells. This phenotypic alteration markedly reduced the noradrenergic innervation originating from the superior cervical ganglia. Although the mechanism by which the reduction occurs is presently unknown, quantitative enzyme-linked immunoassay showed the presence of the equivalent amounts of nerve growth factor (NGF) in the control and transgenic pineal glands, suggesting that it occurred in a NGF-independent manner. The results suggest that target neurotransmitter phenotype influences the formation of afferent connections during development.
authors.affiliation: Labratory of Molecular Neurobiology, Cornell University Medical College, Burke Medical Research Institute, White Plains, NY 10605, USA.
authors.forename: S
authors.initials: S
authors.lastname: Cho
authors.forename: J H
authors.initials: JH
authors.lastname: Son
authors.forename: D H
authors.initials: DH
authors.lastname: Park
authors.forename: C
authors.initials: C
authors.lastname: Aoki
authors.forename: X
authors.initials: X
authors.lastname: Song
authors.forename: G P
authors.initials: GP
authors.lastname: Smith
authors.forename: T H
authors.initials: TH
authors.lastname: Joh
mesh_terms: D000818:Animals; D001369:Axons / Q000201:enzymology* / Q000648:ultrastructure; D018076:DNA, Complementary; D005091:Exons; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008822:Mice, Transgenic; D016253:Microscopy, Immunoelectron; D009414:Nerve Growth Factors / Q000032:analysis / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000201:enzymology* / Q000648:ultrastructure; D010641:Phenotype; D010870:Pineal Gland / Q000502:physiology*; D010957:Plasmids; D015183:Restriction Mapping; D017783:Superior Cervical Ganglion / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D009414:Nerve Growth Factors; D014446:Tyrosine 3-Monooxygenase